NPS RADAR March 2009NPS RADAR March 2009

NPS RADAR articles provide timely, independent, evidence-based assessment of new drugs, new PBS listings and research for health professionals.

Find out more about NPS RADAR.



Title Why read this
Risedronate (Actonel and Actonel Once-a-Week) for corticosteroid-induced osteoporosis Professional publication - NPS RADAR - Brief item The PBS listing for risedronate (Actonel and Actonel Once-a-Week) and risedronate with calcium (Actonel Combi) has been extended to people with corticosteroid-induced osteoporosis (CIO) who are on long-term high-dose corticosteroid therapy.
Desvenlafaxine (Pristiq) for major depressive disorder Professional publication - NPS RADAR - Review Theoretically, desvenlafaxine has lower potential for drug interactions than its parent drug venlafaxine, but this does not appear to confer any particular clinical advantage.
Valsartan (Diovan) and combinations with hydrochlorothiazide (Co-Diovan) or amlodipine (Exforge) Professional publication - NPS RADAR - Review Valsartan reduces blood pressure to a similar extent as other angiotensin II-receptor antagonists. If blood pressure is not controlled by valsartan 160 mg, add a second drug rather than increasing the dose to 320 mg. Establish the effective dose using the individual drugs before prescribing the appropriate combination.
Clopidogrel (Iscover, Plavix) PBS listing extended to include acute coronary syndrome (ACS) in combination with aspirin Professional publication - NPS RADAR - Brief item Clopidogrel (Iscover, Plavix) and aspirin can now be prescribed in combination for acute coronary syndrome (ACS). The extended listing includes the treatment of myocardial infarction (MI) or unstable angina to prevent atherothrombotic events.

Complete list of all NPS RADAR content.

Find out more about NPS RADAR.

Date published: 2009-03-01 00:00:00

Reasonable care is taken to provide accurate information at the date of creation. This information is not intended as a substitute for medical advice from a qualified health professional. Health professionals should rely on their own expertise and enquiries when providing medical advice or treatment. Where permitted by law, NPS disclaims all liability (including for negligence) for any loss, damage or injury resulting from reliance on or use of this information. Read our full disclaimer.

References to brands should not be taken as an endorsement by NPS.